APOE and Alzheimer disease: Not only individuals carrying APOE4 allele show a dose-dependent risk but the relative mRNA level of APOE4 is increased in AD patients compared to controls, indicating that the variability in the neuronal expression of APOE contributes to increase the disease risk [337].